Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
2.11%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth2.11%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
21.22%
60%
—
—
Never
—
5 Years
Score—
Net Growth21.22%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
NextCure Inc fundamental performance
Across NextCure Inc's full reported history, from 2019 to 2025, revenue declined from $ 6M to $ 0.00 and net income went from -$ 33M to -$ 55M. Revenue increased in 14% of the years measured; net income in 57%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 8.17 | — |
1 Year2025-08-12 | $ 4.83 | 68.98% |
5 Years2021-08-12 | $ 87.12 | -90.62% |
All Time2019-05-09 | $ 238.80 | -96.58% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-05-09 |
|---|---|---|---|---|
| Price | $ 8.17 | $ 4.83 | $ 87.12 | $ 238.80 |
| Return | — | 68.98% | -90.62% | -96.58% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 54M | $ 29M |
| 2025 | $ 0.00 | -$ 55M | $ 41M |
| 2024 | $ 0.00 | -$ 55M | $ 68M |
| 2023 | $ 0.00 | -$ 62M | $ 108M |
| 2022 | $ 0.00 | -$ 69M | $ 159M |
| 2021 | $ 0.00 | -$ 69M | $ 219M |
| 2020 | $ 22M | -$ 33M | $ 283M |
| IPO2019 | $ 6M | -$ 33M | $ 334M |
Explore beyond NXTC
You're looking at NextCure Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
